阿兹海默症的新药做个三期要10亿美元，增发新股一次筹$75M，需要14次钱才够。最后能不能通过审批还不知道。

所有跟帖： 

• alzheimer的药太难做了……就算fda一路给绿灯 -Soybean1720- ♀ (0 bytes) () 11/13/2020 postreply 08:46:00

• alzheimer drug too difficult to develop, its like gambling -taiyoucai- ♂ (0 bytes) () 11/13/2020 postreply 08:47:41

• 真不容易 -rainydayy- ♀ (0 bytes) () 11/13/2020 postreply 08:47:44

• Still hold hope on Biogene, they have done a lot of work on thi -12qw- ♀ (104 bytes) () 11/13/2020 postreply 08:51:17

• 就算fda批了，也可能是鸡肋，发挥不了大作用 -Soybean1720- ♀ (0 bytes) () 11/13/2020 postreply 08:54:00

• Everything starts from nothing -12qw- ♀ (0 bytes) () 11/13/2020 postreply 09:00:04

• 如果一直发新股，可能说明大厂不看好这项技术 -hampton001- ♂ (0 bytes) () 11/13/2020 postreply 08:54:23